Welcome to our dedicated page for NATURALSHRIMP news (Ticker: SHMP), a resource for investors and traders seeking the latest updates and insights on NATURALSHRIMP stock.
NaturalShrimp Holdings, Inc., based in San Antonio, Texas, United States, is a leading food production company. Headquartered in Dallas, with production facilities in San Antonio, Texas, and Webster City, Iowa, the company focuses on aquaculture. NaturalShrimp has revolutionized shrimp farming by developing innovative enclosed salt-water systems using patented technology to produce fresh Pacific white shrimp naturally, without the need for antibiotics or toxic chemicals. The company's commitment to sustainability is evident in its recent patent filings in Japan, Thailand, and Australia and its successful 6-month trial of Electrocoagulation and Hydrogas™ technologies in Japan. With plans for expansion and listings on the Chicago Board of Options Exchange, NaturalShrimp is poised for growth and further innovation in the aquaculture sector.
NaturalShrimp, Inc. (OTCQB: SHMP) has reinforced its partnership with Gulf Seafood Inc. to supply live shrimp, extending their trial agreement through Q1 2022. The collaboration has seen successful deliveries since November 2021, utilizing GSI's unique waterless packaging. CEO Gerald Easterling highlighted the potential for increased sales and direct supply from their LaCoste facility starting February. GSI expressed optimism for a long-term arrangement following positive customer feedback during the trial period and plans for expansion into Las Vegas and Florida.
NaturalShrimp, Inc. (OTCQB: SHMP) announced the arrival of equipment to enhance shrimp production and support a second phase salmon trial. The company is installing twenty electrocoagulation units at its LaCoste, TX and Webster City, IA facilities, despite supply chain delays. Additionally, Hydrogas reactors for aquaculture have been delivered to both U.S. facilities and Norway. The salmon trial at Marineholmen RASLab in Norway starts February 1, 2022, aiming to validate the use of Hydrogas and electrocoagulation technologies for improved fish health and production.
NaturalShrimp, Inc. (OTCQB: SHMP) has announced a groundbreaking advancement from its technical team, demonstrating that their patented electrocoagulation (EC) technology can effectively reduce nitrites in recirculating aquaculture systems (RAS) without requiring a biofilter. This capability enhances their Vibrio Suppression Technology, improving water quality and production efficiency. The company aims to leverage these technologies for potential licensing opportunities, positioning itself favorably in the aquaculture market. NaturalShrimp specializes in antibiotic-free shrimp farming using innovative enclosed RAS technology.
NaturalShrimp, Inc. (OTCQB: SHMP) announced plans to expand shrimp production at its facilities in Texas and Iowa, with new facilities in Florida and Nevada. A new 80,000 sq. ft. production building in La Coste, TX will triple output. In Iowa, retrofitting of the Webster City facility is set to begin, and a joint venture aims to build a 240,000 sq. ft. facility in Florida, pending funding. Additionally, a 480,000 sq. ft. facility in Nevada is in planning. CEO Gerald Easterling indicated that these expansions are crucial to meet increasing demand for their gourmet-grade shrimp.
NaturalShrimp, Inc. (OTCQB: SHMP) has announced funding for a second freshwater salmon trial at Marineholmen RASLab in Norway. Following promising results from a previous study using Hydrogas technology, the new trial aims to validate the effectiveness of both Hydrogas and patented electrocoagulation (EC) technology. CEO Gerald Easterling stated that these advancements could significantly enhance shrimp production and open new revenue streams through technology licensing. Results from the trial are expected later in 2022.
NaturalShrimp, Inc. (OTCQB: SHMP) announced a ramp-up in live shrimp sales to Gulf Seafood Inc. (GSI), following successful deliveries in November under a trial purchase agreement for 25,000 pounds. The company cites increasing demand for smaller shrimp, enhancing profit margins due to shorter grow-out periods. A new facility in Las Vegas is planned to boost geographical reach and distribution capabilities for live shrimp. Management highlights potential gross margins for smaller shrimp being 3-4 times higher than larger varieties, presenting significant financial opportunities.
NaturalShrimp, Inc. (OTCQB: SHMP) announced the sale of a 12% Secured Promissory Note totaling $16.32 million to Streeterville Capital, LLC, aiming to expand production in Texas and Iowa. The offering, which incurred around $1.32 million in fees, will also cover a renegotiated balance of a previous $5 million debt, lowered to $4.5 million. The note matures in 24 months and carries a 12% interest rate. CEO Gerald Easterling highlighted the company's growth strategy, including an upcoming up-listing to a major exchange.
NaturalShrimp, Inc. (SHMP) announces the appointment of W. Steven Walker as General Counsel and Secretary, effective January 1, 2022. Walker, a veteran attorney with over 45 years of experience, has been affiliated with the company since 2001 and brings extensive knowledge of corporate and transactional law. CEO Gerald Easterling emphasized the need for legal counsel to manage operational issues amid the company's rapid growth and commercialization. NaturalShrimp is known for its innovative Recirculating Aquaculture System, producing fresh, antibiotic-free shrimp.
NaturalShrimp, Inc. (OTCQB: SHMP) has achieved a significant milestone by successfully delivering the first commercial shipments of live shrimp to Gulf Seafood Inc. as part of a three-month trial. The agreement, announced in October, includes the delivery of 25,000 pounds of shrimp utilizing GSI's innovative waterless packaging method. The company also reported the development of a state-of-the-art packaging facility in Iowa, enhancing its operational capabilities. CEO Gerald Easterling emphasized the importance of these deliveries in validating NaturalShrimp's patented RAS technology for growing gourmet-grade shrimp.
NaturalShrimp, Inc. (OTCQB: SHMP) will participate in the 10th Annual Technology & Inaugural AgTech Answers Virtual Event from November 16-18, 2021. CEO Gerald Easterling and COO Tom Untermeyer will host one-on-one meetings on November 16. The event is invitation-only and registration is required. NaturalShrimp specializes in innovative shrimp farming technology, utilizing patented Recirculating Aquaculture Systems (RAS) to produce fresh, gourmet-grade shrimp without antibiotics or toxic chemicals, with facilities in Texas and Iowa.
FAQ
What is the current stock price of NATURALSHRIMP (SHMP)?
What is the market cap of NATURALSHRIMP (SHMP)?
Where is NaturalShrimp headquartered?
What sets NaturalShrimp apart in the aquaculture industry?
What recent achievements has NaturalShrimp made?
What are the expansion plans for NaturalShrimp?
